{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "68-year-old man diagnosed with advanced lung adenocarcinoma (KRAS mutated) with synchronous hepatic, pulmonary, and bone metastases. Patient had painful L1 spinal epiduritis.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "Lung cancer",
              "status": "active"
            },
            {
              "code": "C79.0",
              "label": "Secondary malignant neoplasm of kidney and renal pelvis",
              "status": "active"
            },
            {
              "code": "C79.51",
              "label": "Secondary malignant neoplasm of bone",
              "status": "active"
            }
          ],
          "HPI": [
            {
              "summary": "Patient had painful L1 spinal epiduritis."
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Tridimensional conformational radiotherapy was delivered to the vertebra T12 - L2, at a dose of 30 Gy in 10 fractions and 12 days.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Three-dimensional conformal radiation therapy",
              "approach": "other",
              "date": null,
              "location": "T12-L2 vertebra",
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Fifteen days after radiotherapy, immunotherapy was initiated using pembrolizumab (PD-L1 expression score > 50%, no EGFR mutations nor ALK translocations).",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1877844",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "C0034587",
              "approach": null,
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "After 8 cycles (24 weeks) of pembrolizumab, CT evaluation showed an almost complete tumor response. Patient began to present muscle weakness in the left lower limb, paresthesia, difficulty urinating, and rapid bowel movements.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C3876533",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "C0009450"
            }
          ],
          "imaging": [
            {
              "type": "C0027673",
              "body_part": null,
              "modality": "CT",
              "finding": "almost complete tumor response",
              "impression": null,
              "date": null
            }
          ],
          "HPI": [
            {
              "summary": "Patient began to present muscle weakness in the left lower limb, paresthesia, difficulty urinating, and rapid bowel movements.",
              "duration": null,
              "onset": null,
              "progression": null,
              "associated_symptoms": [
                "C0221077",
                "C0030554",
                "C0013360",
                "C0006202"
              ],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "MRI of the spine showed spinal cord edema with T1 hypointense signal and patchy gadolinium enhancement at T12-L1 levels. Cerebrospinal fluid analysis revealed moderately elevated proteinorachy (0.84 g/l).",
        "clinical_data": {
          "imaging": [
            {
              "type": "Magnetic Resonance Imaging",
              "body_part": "Spine",
              "modality": "MRI",
              "finding": "Spinal cord edema",
              "date": null
            }
          ],
          "labs": [
            {
              "test": "Proteinorachy",
              "value": "0.84",
              "unit": "g/l",
              "flag": "abnormal",
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Intrathecal immunoglobulin synthesis was negative. Antineural antibodies were not detected. Cytology was negative for inflammatory or tumor cells. Pembrolizumab was discontinued. Patient received oral steroid treatment (60 mg/day), tapered over 2 months.",
        "clinical_data": {
          "labs": [
            {
              "test": "Intrathecal immunoglobulin synthesis",
              "value": "negative"
            },
            {
              "test": "Antineural antibodies",
              "value": "not detected"
            },
            {
              "test": "Cytology",
              "value": "negative",
              "finding": "inflammatory or tumor cells"
            }
          ],
          "medications": [
            {
              "drug": "Pembrolizumab",
              "end_date": null
            },
            {
              "drug": "Steroid",
              "dosage": "60 mg/day",
              "modality": "oral",
              "end_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "After 48 hours of steroid therapy, significant improvement of symptomatology was observed. Symptoms completely disappeared after 3 weeks.",
        "clinical_data": {}
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "After 14 weeks, the patient remained asymptomatic, with radiological improvement in myelitis (Fig.1f).",
        "clinical_data": {
          "imaging": [
            {
              "type": "Myelitis",
              "body_part": "Spinal Cord",
              "modality": "MRI",
              "finding": "Radiological improvement",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Pulmonary disease progression was noted (Fig.2c).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0034063",
              "label": "Pulmonary Disease",
              "status": "active"
            }
          ],
          "imaging": [
            {
              "finding": "Pulmonary disease progression",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Pembrolizumab was resumed.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Pembrolizumab",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N11",
      "label": "Step 11",
      "customData": {
        "node_id": "K",
        "node_step_index": 10,
        "content": "After 8 cycles of pembrolizumab, no relapse of myelitis was observed clinically nor radiologically. CT reevaluation showed partial tumor response (Fig.2d).",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1661229",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "imaging": [
            {
              "type": "C0009026",
              "body_part": null,
              "modality": "CT",
              "finding": "partial tumor response",
              "impression": null,
              "date": null
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "myelitis",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N12",
      "label": "Step 12",
      "customData": {
        "node_id": "L",
        "node_step_index": 11,
        "content": "Initial MRI at epiduritis diagnosis showed osseous metastasis of L1 with epiduritis, but no enhancement of the spinal cord.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Magnetic Resonance Imaging",
              "body_part": "Spinal Cord",
              "modality": "MRI",
              "finding": "no enhancement",
              "date": null
            },
            {
              "type": "Magnetic Resonance Imaging",
              "body_part": "Spine",
              "modality": "MRI",
              "finding": "osseous metastasis of L1 with epiduritis",
              "date": null
            }
          ],
          "diagnoses": [
            {
              "code": "Epiduritis",
              "label": "Epiduritis",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "Metastasis",
              "label": "Metastasis",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N13",
      "label": "Step 13",
      "customData": {
        "node_id": "M",
        "node_step_index": 12,
        "content": "MRI after the first signs of myelitis showed abnormal enhancement of the conus medullaris, and regression of osseous involvement and epiduritis.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Magnetic Resonance Imaging",
              "body_part": "Conus Medullaris",
              "modality": "MRI",
              "finding": "abnormal enhancement",
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N14",
      "label": "Step 14",
      "customData": {
        "node_id": "N",
        "node_step_index": 13,
        "content": "CT scan at baseline showing hepatic metastases of the lung adenocarcinoma.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Computed tomography",
              "body_part": "Liver",
              "modality": "CT",
              "finding": "Hepatic metastases",
              "impression": "Hepatic metastases of the lung adenocarcinoma"
            }
          ],
          "diagnoses": [
            {
              "code": "C34",
              "label": "Lung adenocarcinoma",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N15",
      "label": "Step 15",
      "customData": {
        "node_id": "O",
        "node_step_index": 14,
        "content": "CT scan shows a partial response after 8 cycles of immunotherapy.",
        "clinical_data": {
          "imaging": [
            {
              "modality": "CT",
              "finding": "partial response",
              "date": null
            }
          ],
          "procedures": [
            {
              "name": "Immunotherapy",
              "date": null,
              "outcome": "partial response"
            }
          ]
        }
      }
    },
    {
      "id": "N16",
      "label": "Step 16",
      "customData": {
        "node_id": "P",
        "node_step_index": 15,
        "content": "MRI at 1",
        "clinical_data": {
          "imaging": [
            {
              "type": "MRI",
              "date": "1"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Treatment with tridimensional conformational radiotherapy."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Initiation of pembrolizumab immunotherapy fifteen days after radiotherapy.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1877844"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "After 8 cycles of pembrolizumab, CT evaluation showed an almost complete tumor response. Patient began to present muscle weakness in the left lower limb, paresthesia, difficulty urinating, and rapid bowel movements.",
        "transition_event": {
          "trigger_type": "interpretation",
          "trigger_entities": [
            "C0027673"
          ],
          "change_type": "progression",
          "target_domain": "imaging"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "MRI of the spine showed spinal cord edema with T1 hypointense signal and patchy gadolinium enhancement at T12-L1 levels. Cerebrospinal fluid analysis revealed moderately elevated proteinorachy (0.84 g/l)."
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Intrathecal immunoglobulin synthesis was negative. Antineural antibodies were not detected. Cytology was negative for inflammatory or tumor cells. Pembrolizumab was discontinued. Patient received oral steroid treatment (60 mg/day), tapered over 2 months.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1877844"
          ],
          "change_type": "discontinuation",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "After 48 hours of steroid therapy, significant improvement of symptomatology was observed. Symptoms completely disappeared after 3 weeks.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "Steroid"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "After 14 weeks, the patient remained asymptomatic, with radiological improvement in myelitis."
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Pulmonary disease progression was noted."
      }
    },
    {
      "from": "N9",
      "to": "N10",
      "data": {
        "edge_id": "I_to_J",
        "branch_flag": true,
        "content": "Pembrolizumab was resumed.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1877844"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N10",
      "to": "N11",
      "data": {
        "edge_id": "J_to_K",
        "branch_flag": true,
        "content": "After 8 cycles of pembrolizumab, no relapse of myelitis was observed clinically nor radiologically. CT reevaluation showed partial tumor response."
      }
    },
    {
      "from": "N11",
      "to": "N12",
      "data": {
        "edge_id": "K_to_L",
        "branch_flag": true,
        "content": "Initial MRI at epiduritis diagnosis showed osseous metastasis of L1 with epiduritis, but no enhancement of the spinal"
      }
    }
  ]
}